Gastrointestinal Drugs Market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 42,180 Million in 2018 and is projected to register a valuation of USD 59,300 Million by 2025, with a CAGR of 4.9% over the forecast period.
The increasing prevalence of gastrointestinal diseases and rising investments and funding in the field of life science research are likely to provide favorable conditions for the growth of the market during the forecast period.
Various other factors, such as the changing lifestyle and increasing number of geriatric individuals, are also expected to propel the growth of the market.
However, high raw material costs and growing presence of counterfeit drugs can hamper market growth over the forecast period.
Segmentation
The global gastrointestinal drugs market is segmented based on drug class, route of administration, application, distribution channel, and region.
The global market for gastrointestinal drugs, by drug class, is segmented into acid neutralizers, anti-inflammatory drugs, antidiarrheal and laxatives, antiemetic and antinauseants, biologics, and others.
Based on route of administration, the market is segmented into oral, parenteral, and rectal.
Based on Application, the market is segmented into inflammatory ulcerative colitis, irritable bowel syndrome, Crohn's disease, celiac disease, gastroenteritis, and others.
Distribution channels are segmented into retail pharmacies, online pharmacies, and hospital pharmacies.
Key Players
Some of the Key Players operating in the Global Gastrointestinal Drugs Market are Takeda Pharmaceuticals, Allergan Plc, Novo Nordisk A/S, AstraZeneca Plc, AbbVie Inc., Valeant Pharmaceuticals Inc., Johnson & Johnson, Bayer AG, Boehringer Ingelheim GmbH, GlaxoSmithKline Plc., Janssen Biotech Inc., and Sanofi.
Market Segmentation
Global Gastrointestinal Drugs Market, by Drug Class
- Acid Neutralizers
- Antacids
- H2 Antagonists
- Proton Pump Inhibitors
- Anti-inflammatory Drugs
- Antidiarrheal and Laxatives
- Antiemetic and Antinauseants
- Biologics
- Others
Global Gastrointestinal Drugs Market, by Route of Administration
Global Gastrointestinal Drugs Market, by Application
- Inflammatory Ulcerative Colitis
- Irritable Bowel Syndrome
- Crohn's Disease
- Celiac Disease
- Gastroenteritis
- Others
Global Gastrointestinal Drugs Market, by Distribution Channel
- Retail Pharmacies
- Online Pharmacies
- Hospital Pharmacies
Request Customization
Get a Sample
Get a Sample
Request Customization